Richard Massey is a President and CEO at Covalent Bioscience, Inc. Company`s inventions and discoveries over 30+ years of academic research have brought the science of Catalytic Immunotherapy and E-vaccines to the brink of medical intervention. Richard is highly knowledgeable in the basic science of catabodies and E-vaccines, and he has a deep understanding of the unique commercial opportunities for these technologies.